Asia-Pacific Oncology Market Outlook to 2033: Colorectal Cancer Screening Tests, EGFR Tests, KRAS Tests and Others

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

$5995
Buy Report

Published: September 04, 2025 Report Code: GDME20429CRDB-ST

Select Item

GlobalData’s “Asia-Pacific Oncology Market Outlook to 2033” is a comprehensive databook report, covering key market data on the Asia-Pacific Oncology market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments – Colorectal Cancer Screening Tests, EGFR Tests, KRAS Tests, HER2 Tests, BRCA Tests
ALK Tests, BRAF Tests, BCR-ABL Tests and PD-L1 Tests

The Asia-Pacific Oncology Market report provides key information and data on –
• Annualized market revenues (USD), volume (units) and average prices (USD) data for each of the market segments. Data is provided from 2018 to 2033.
• 2023 company share data for Oncology Market.
• Global corporate-level profiles of key companies operating within the Asia-Pacific Oncology Market. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is also available in the report.

Scope

Asia-Pacific Oncology is segmented as follows – _x000D_

• Colorectal Cancer Screening Tests_x000D_

• EGFR Tests_x000D_

• KRAS Tests_x000D_

• HER2 Tests_x000D_

• BRCA Tests_x000D_

• ALK Tests_x000D_

• BRAF Tests_x000D_

• BCR-ABL Tests_x000D_

• PD-L1 Tests

Reasons to Buy

The Asia-Pacific Oncology Market report helps you to develop –

• Business strategies by identifying the key market segments poised for strong growth in the future.

• Market-entry and market expansion strategies.

• Design competition strategies by identifying who-stands-where in the market.

• Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.

F. Hoffmann-La Roche Ltd_x000D_
BioGenex Laboratories Inc_x000D_
Agilent Technologies Inc_x000D_
Abbott Laboratories_x000D_
Danaher Corp_x000D_
Amoy Diagnostics Co Ltd_x000D_
Eiken Chemical Co Ltd_x000D_
Alfresa Pharma Corp_x000D_
Hemosure Inc_x000D_
Qiagen NV_x000D_
Sentinel CH. SpA

Table of Contents

|1 Table of Contents 3

|1.1 List of Tables 9

|1.2 List of Figures 11

2 Introduction 13

2.1 What Is This Report About? 13

2.2 Oncology Market Segmentation 13

2.3 Definitions of Markets Covered in the Report 15

3 Oncology Market, Asia-Pacific 22

3.1 Oncology Market, Asia-Pacific, Revenue ($m), 2018-2033 22

3.2 Oncology Market, Asia-Pacific, Revenue ($m), 2018-2033 24

3.3 Oncology Market, Asia-Pacific, Volume (Units), 2018-2033 27

3.4 Oncology Market, Asia-Pacific, Volume (Units), 2018-2033 29

3.5 Oncology Market, Asia-Pacific, Company Share by Revenue ($m), 2024 32

4 Oncology Market, China 34

4.1 Oncology Market, China, Revenue ($m), 2018-2033 34

4.1.1 ALK Tests Market, China, Revenue ($m), by Segment, 2018-2033 37

4.1.2 BCR-ABL Nucleic Acid Amplification Tests (NAATs) Market, China, Revenue ($m), by Segment, 2018-2033 39

4.1.3 BRAF Tests Market, China, Revenue ($m), by Segment, 2018-2033 41

4.1.4 BRCA Tests Market, China, Revenue ($m), by Segment, 2018-2033 43

4.1.5 Colorectal Cancer Screening Tests Market, China, Revenue ($m), by Segment, 2018-2033 45

4.1.6 EGFR Tests Market, China, Revenue ($m), by Segment, 2018-2033 47

4.1.7 HER2 Tests Market, China, Revenue ($m), by Segment, 2018-2033 49

4.1.8 KRAS Tests Market, China, Revenue ($m), by Segment, 2018-2033 51

4.2 Oncology Market, China, Volume (Units), 2018-2033 53

4.2.1 ALK Tests Market, China, Volume (Units), by Segment, 2018-2033 56

4.2.2 BCR-ABL Tests Market, China, Volume (Units), by Segment, 2018-2033 58

4.2.3 BRAF Tests Market, China, Volume (Units), by Segment, 2018-2033 60

4.2.4 BRCA Tests Market, China, Volume (Units), by Segment, 2018-2033 62

4.2.5 Colorectal Cancer Screening Tests Market, China, Volume (Units), by Segment, 2018-2033 64

4.2.6 EGFR Tests Market, China, Volume (Units), by Segment, 2018-2033 66

4.2.7 HER2 Tests Market, China, Volume (Units), by Segment, 2018-2033 68

4.2.8 KRAS Tests Market, China, Volume (Units), by Segment, 2018-2033 70

4.3 Oncology Market, China, Average Price ($) , 2018-2033 72

4.4 Oncology Market, China, Company Share by Revenue ($m), 2024 75

5 Oncology Market, South Korea 77

5.1 Oncology Market, South Korea, Revenue ($m), 2018-2033 77

5.1.1 ALK Tests Market, South Korea, Revenue ($m), by Segment, 2018-2033 80

5.1.2 BCR-ABL Tests Market, South Korea, Revenue ($m), by Segment, 2018-2033 82

5.1.3 BRAF Tests Market, South Korea, Revenue ($m), by Segment, 2018-2033 84

5.1.4 BRCA Tests Market, South Korea, Revenue ($m), by Segment, 2018-2033 86

5.1.5 Colorectal Cancer Screening Tests Market, South Korea, Revenue ($m), by Segment, 2018-2033 88

5.1.6 EGFR Tests Market, South Korea, Revenue ($m), by Segment, 2018-2033 90

5.1.7 HER2 Tests Market, South Korea, Revenue ($m), by Segment, 2018-2033 92

5.1.8 KRAS Tests Market, South Korea, Revenue ($m), by Segment, 2018-2033 94

5.2 Oncology Market, South Korea, Volume (Units), 2018-2033 96

5.2.1 ALK Tests Market, South Korea, Volume (Units), by Segment, 2018-2033 99

5.2.2 BCR-ABL Tests Market, South Korea, Volume (Units), by Segment, 2018-2033 101

5.2.3 BRAF Tests Market, South Korea, Volume (Units), by Segment, 2018-2033 103

5.2.4 BRCA Tests Market, South Korea, Volume (Units), by Segment, 2018-2033 105

5.2.5 Colorectal Cancer Screening Tests Market, South Korea, Volume (Units), by Segment, 2018-2033 107

5.2.6 EGFR Tests Market, South Korea, Volume (Units), by Segment, 2018-2033 109

5.2.7 HER2 Tests Market, South Korea, Volume (Units), by Segment, 2018-2033 111

5.2.8 KRAS Tests Market, South Korea, Volume (Units), by Segment, 2018-2033 113

5.3 Oncology Market, South Korea, Average Price ($), 2018-2033 115

5.4 Oncology Market, South Korea, Company Share by Revenue ($m), 2024 119

6 Oncology Market, Australia 121

6.1 Oncology Market, Australia, Revenue ($m), 2018-2033 121

6.1.1 ALK Tests Market, Australia, Revenue ($m), by Segment, 2018-2033 124

6.1.2 BCR-ABL Tests Market, Australia, Revenue ($m), by Segment, 2018-2033 126

6.1.3 BRAF Tests Market, Australia, Revenue ($m), by Segment, 2018-2033 128

6.1.4 BRCA Tests Market, Australia, Revenue ($m), by Segment, 2018-2033 130

6.1.5 Colorectal Cancer Screening Tests Market, Australia, Revenue ($m), by Segment, 2018-2033 132

6.1.6 EGFR Tests Market, Australia, Revenue ($m), by Segment, 2018-2033 134

6.1.7 HER2 Tests Market, Australia, Revenue ($m), by Segment, 2018-2033 136

6.1.8 KRAS Tests Market, Australia, Revenue ($m), by Segment, 2018-2033 138

6.2 Oncology Market, Australia, Volume (Units), 2018-2033 140

6.2.1 ALK Tests Market, Australia, Volume (Units), by Segment, 2018-2033 143

6.2.2 BCR-ABL Tests Market, Australia, Volume (Units), by Segment, 2018-2033 145

6.2.3 BRAF Tests Market, Australia, Volume (Units), by Segment, 2018-2033 147

6.2.4 BRCA Tests Market, Australia, Volume (Units), by Segment, 2018-2033 149

6.2.5 Colorectal Cancer Screening Tests Market, Australia, Volume (Units), by Segment, 2018-2033 151

6.2.6 EGFR Tests Market, Australia, Volume (Units), by Segment, 2018-2033 153

6.2.7 HER2 Tests Market, Australia, Volume (Units), by Segment, 2018-2033 155

6.2.8 KRAS Tests Market, Australia, Volume (Units), by Segment, 2018-2033 157

6.3 Oncology Market, Australia, Average Price ($) , 2018-2033 159

6.4 Oncology Market, Australia, Company Share by Revenue ($m), 2024 163

7 Oncology Market, India 165

7.1 Oncology Market, India, Revenue ($m), 2018-2033 165

7.1.1 ALK Tests Market, India, Revenue ($m), by Segment, 2018-2033 168

7.1.2 BCR-ABL Tests Market, India, Revenue ($m), by Segment, 2018-2033 170

7.1.3 BRAF Tests Market, India, Revenue ($m), by Segment, 2018-2033 172

7.1.4 BRCA Tests Market, India, Revenue ($m), by Segment, 2018-2033 174

7.1.5 Colorectal Cancer Screening Tests Market, India, Revenue ($m), by Segment, 2018-2033 176

7.1.6 EGFR Tests Market, India, Revenue ($m), by Segment, 2018-2033 178

7.1.7 HER2 Tests Market, India, Revenue ($m), by Segment, 2018-2033 180

7.1.8 KRAS Tests Market, India, Revenue ($m), by Segment, 2018-2033 182

7.2 Oncology Market, India, Volume (Units), 2018-2033 184

7.2.1 ALK Tests Market, India, Volume (Units), by Segment, 2018-2033 187

7.2.2 BCR-ABL Tests Market, India, Volume (Units), by Segment, 2018-2033 189

7.2.3 BRAF Tests Market, India, Volume (Units), by Segment, 2018-2033 191

7.2.4 BRCA Tests Market, India, Volume (Units), by Segment, 2018-2033 193

7.2.5 Colorectal Cancer Screening Tests Market, India, Volume (Units), by Segment, 2018-2033 195

7.2.6 EGFR Tests Market, India, Volume (Units), by Segment, 2018-2033 197

7.2.7 HER2 Tests Market, India, Volume (Units), by Segment, 2018-2033 199

7.2.8 KRAS Tests Market, India, Volume (Units), by Segment, 2018-2033 201

7.3 Oncology Market, India, Average Price ($) , 2018-2033 203

7.4 Oncology Market, India, Company Share by Revenue ($m), 2024 207

8 Oncology Market, Japan 209

8.1 Oncology Market, Japan, Revenue ($m), 2018-2033 209

8.1.1 ALK Tests Market, Japan, Revenue ($m), by Segment, 2018-2033 212

8.1.2 BCR-ABL Tests Market, Japan, Revenue ($m), by Segment, 2018-2033 214

8.1.3 BRAF Tests Market, Japan, Revenue ($m), by Segment, 2018-2033 216

8.1.4 BRCA Tests Market, Japan, Revenue ($m), by Segment, 2018-2033 218

8.1.5 Colorectal Cancer Screening Tests Market, Japan, Revenue ($m), by Segment, 2018-2033 220

8.1.6 EGFR Tests Market, Japan, Revenue ($m), by Segment, 2018-2033 222

8.1.7 HER2 Tests Market, Japan, Revenue ($m), by Segment, 2018-2033 224

8.1.8 KRAS Tests Market, Japan, Revenue ($m), by Segment, 2018-2033 226

8.2 Oncology Market, Japan, Volume (Units), 2018-2033 228

8.2.1 ALK Tests Market, Japan, Volume (Units), by Segment, 2018-2033 231

8.2.2 BCR-ABL Tests Market, Japan, Volume (Units), by Segment, 2018-2033 233

8.2.3 BRAF Tests Market, Japan, Volume (Units), by Segment, 2018-2033 235

8.2.4 BRCA Tests Market, Japan, Volume (Units), by Segment, 2018-2033 237

8.2.5 Colorectal Cancer Screening Tests Market, Japan, Volume (Units), by Segment, 2018-2033 239

8.2.6 EGFR Tests Market, Japan, Volume (Units), by Segment, 2018-2033 241

8.2.7 HER2 Tests Market, Japan, Volume (Units), by Segment, 2018-2033 243

8.2.8 KRAS Tests Market, Japan, Volume (Units), by Segment, 2018-2033 245

8.3 Oncology Market, Japan, Average Price ($) , 2018-2033 247

8.4 Oncology Market, Japan, Company Share by Revenue ($m), 2024 250

9 Overview of Key Companies in Asia-Pacific Oncology Market 252

9.1 F. Hoffmann-La Roche Ltd 252

9.1.1 Company Overview 252

9.2 BioGenex Laboratories Inc 252

9.2.1 Company Overview 252

9.3 Amoy Diagnostics Co Ltd 252

9.3.1 Company Overview 252

9.4 Abbott Laboratories 252

9.4.1 Company Overview 252

9.5 Danaher Corp 253

9.5.1 Company Overview 253

9.6 Eiken Chemical Co Ltd 253

9.6.1 Company Overview 253

9.7 Agilent Technologies Inc 253

9.7.1 Company Overview 253

9.8 Hemosure Inc 253

9.8.1 Company Overview 253

9.9 Alfresa Pharma Corp 253

9.9.1 Company Overview 253

9.10 Qiagen NV 254

9.10.1 Company Overview 254

9.11 Sentinel CH. SpA 254

9.11.1 Company Overview 254

10 Oncology Market Pipeline Products 255

11 Recent Developments 409

11.1 Corporate Communications 409

11.1.1 Apr 07, 2025: Ono Pharmaceutical Makes Changes of Board of Directors and Corporate Officers 409

11.1.2 Oct 08, 2024: Opthea Announces New Senior Hires 409

11.1.3 Oct 08, 2024: National Accreditation Program for Breast Centers Optimal Resources for Breast Care Standards updated to recommend use of Lymphoedema Prevention Programs, including Bioimpedance Spectroscopy 410

11.1.4 Aug 23, 2024: Caris Life Sciences Announces Appointment of Dave Fredrickson to Board of Directors 410

11.2 Financial Announcements 411

11.2.1 May 08, 2025: Ono Pharmaceutical Reports Results for Fiscal Year Ended March 31, 2025 411

11.2.2 Nov 08, 2024: Human Metabolome Announces Consolidated Financial Results for the First Quarter of Fiscal Year Ending June 30, 2025 411

11.2.3 Aug 01, 2024: Astellas Pharma Announces Financial Results for Q1 FY2024 411

11.3 Government and Public Interest 412

11.3.1 Jun 10, 2025: Dual-laser Strategy Revolutionizes Breast Cancer Photothermal Therapy 412

11.3.2 May 22, 2025: Boosting Cancer Treatment: NUS Researchers Develop Efficient ‘Food Delivery Service’ for Transporting Cancer-Fighting Genes 412

11.3.3 May 08, 2025: Number of Patients Registered for Cancer Gene Panel Testing Under Health Insurance Coverage Reaches 100,000 413

11.4 Other Significant Developments 415

11.4.1 Jun 23, 2025: Icon Group and Varian Expand Global Partnership To Deliver Advanced Cancer Technology Across the UK 415

11.4.2 Apr 16, 2025: PODO Therapeutics Unveils Predictive Platform for Immuno-Oncology and Radiation Sensitivity at AACR 2025 415

11.4.3 Mar 03, 2025: TruScreen – Key Markets Update and Revenue Guidance 416

11.4.4 Feb 27, 2025: Avitia Launches AI-Powered Platform for Rapid & Point-Of-Care Cancer Testing 417

11.4.5 Feb 21, 2025: The OhmX RAMP UP Grant Awarded to 15 Laboratories to Advance Genomic Research 418

11.4.6 Feb 11, 2025: Alcidion Receives Contract With Hywel Dda University Health Board in Wales 419

11.4.7 Jan 27, 2025: Medicare LCD Effective Date Extended to 24 April 2025 419

11.4.8 Nov 25, 2024: ACRF Awards $20 Million to Support Transformative Australian Cancer Research: World-First Total-Body PET/CT Scanning Tech; Reducing Childhood Cancer Deaths; And Revolutionising Immunotherapies 419

11.4.9 Nov 25, 2024: Australian Cancer Research Foundation Awards $5 Million Major Grant to Launch World-Leading Childhood Cancer Early Detection, Prevention and Treatment Program 421

11.4.10 Nov 25, 2024: ACRF Funding Enables Access to State-Of-The-Art Imaging Technology Set to Improve Immunotherapy Effectiveness and Reduce Toxicity Currently Experienced in up to 30% of Patients 422

11.4.11 Nov 20, 2024: SD Biosensor and the NCCD Discuss Cooperation Measures to Eradicate Infectious Diseases 422

11.4.12 Nov 11, 2024: HKBN x INDICAID Introduce Hong Kong's First At-Home Health Test Monthly Subscription Service 423

11.4.13 Oct 22, 2024: Telix Spins off Rhine Pharma to Expand Global Access to Radiopharmaceuticals 423

11.4.14 Oct 08, 2024: National Accreditation Program for Breast Centers Optimal Resources for Breast Care Standards updated to recommend use of Lymphoedema Prevention Programs, including Bioimpedance Spectroscopy 424

11.4.15 Sep 12, 2024: BioNexus Gene Lab Corp. Signs Strategic Partnership MOU with Shenzhen Rongguang Group to Advance Cancer Screening, Precision Medicine, and Preventative Healthcare Solutions 425

11.4.16 Sep 11, 2024: Thermo Fisher Scientific Announces Oncomine Clinical Research Grant Awardees, Including First Recipients in India and the Netherlands 425

11.4.17 Aug 05, 2024: 10x Genomics Technology Supports TenK10K Project Led by Garvan Institute of Medical Research to Help Transform the Treatment of Complex Diseases 426

11.4.18 Jul 29, 2024: NUS Researchers Develop a Novel Technique to Fabricate Three-Dimensional Circuits for Advanced Electronics 427

11.4.19 Jul 25, 2024: Predictive Oncology Enters Biomarker Discovery Market After Successful Retrospective Ovarian Cancer Study Yields Compelling Results 428

11.5 Product News 428

11.5.1 May 29, 2025: Concord Healthcare Announces Official Release of the Proton Therapy Large Model 428

11.5.2 May 29, 2025: Next-Gen Biobattery Shrinks Tumour, Paving Way for Drug-Free Cancer Treatments 429

11.5.3 Apr 27, 2025: The Group’s Early Detection Product for Urinary System Tumors Achieves Its First Commercial Prescription in Mainland China 429

11.5.4 Apr 16, 2025: PODO Therapeutics Unveils Predictive Platform for Immuno-Oncology and Radiation Sensitivity at AACR 2025 431

11.5.5 Apr 15, 2025: New Study Unveils Revolutionary Chip Technology for Studying Tumor Spheroid-Endothelial Interactions 431

11.5.6 Mar 25, 2025: DNA + RNA Dual-Workflow Synergy for Comprehensive and Precise Detection of Hematologic Malignancy 432

11.5.7 Mar 24, 2025: Research Shows Importance of Genomic Testing and Targeted Therapies for Advanced Cancers 433

11.5.8 Mar 02, 2025: ONJCRI Researchers Pave the Way for Next-Generation Gene Editing in Cancer Research 433

11.5.9 Feb 16, 2025: HKU Team Develops AI-Driven Tool to Accelerate Cancer Diagnosis 434

11.5.10 Feb 14, 2025: New Patent Approval in China Strengthens the AroCell Patent Portfolio 435

11.5.11 Jan 28, 2025: Datar Cancer Genetics To Provide Groundbreaking Video-Enhanced Results of In-Vitro Chemotherapy Effectiveness Tests for Cancer Patients 435

11.5.12 Jan 23, 2025: Guardant Health To Present Data at ASCO GI Demonstrating the Value of Its Precision Oncology Tools for Cancer Detection, Treatment Decisions and Therapy Development 436

11.5.13 Jan 16, 2025: Landmark Publication Highlights Diagnostic Potential of RoXsta 436

11.5.14 Jan 15, 2025: CMU Healthcare System and Nobel Laureate Randy Schekman Drive New Frontiers in Exosome Technology 437

11.5.15 Dec 18, 2024: Clarity Announces Expansion of Pipeline With Novel Optimised FAP-Targeted Radiopharmaceutical 438

11.5.16 Nov 29, 2024: Gene Solutions to Present 1 Oral and 9 Posters at the ESMO Asia Congress 2024 439

11.5.17 Nov 11, 2024: Report Published by Research Journal, Germany’s Springer Concluded that TruScreen Cervical Cancer Screening Results were Comparable and Better than conventional LBC 439

11.5.18 Nov 07, 2024: Nec and Nec Bio Publish Foundational Work on T Cell Receptor Engineering Using Proprietary Generative AI at the Society for Immunotherapy of Cancer Annual Meeting 440

11.5.19 Nov 05, 2024: National Cancer Center, Premia, and Paradigm Launch Treatment Development Platform “LC-SCRUM-CD'' 440

11.5.20 Oct 25, 2024: Volpara Health Surpasses 300 Peer-Reviewed Papers 441

11.5.21 Oct 16, 2024: Telix Featured in 13 Abstracts at the Annual Congress of the European Association of Nuclear Medicine (EANM) 442

11.5.22 Sep 27, 2024: A US patent titled "Biomarkers for lung cancer stem cells" has been granted 444

11.5.23 Sep 26, 2024: Takara Bio Europe Unveils New Large-Scale NGS Profiling System and Chemistries 444

11.5.24 Sep 24, 2024: Industry-Academia Collaboration Nationwide Cancer Genome Screening SCRUM-Japan Launches Fifth Project 445

11.5.25 Sep 20, 2024: Researchers Use Cholesterol-Enriched Exosomes to Improve Sirna Delivery 447

11.5.26 Sep 20, 2024: Approval for Manufacturing and Marketing of “Hemcyte®,” Japan’s First Gene Panel Test for Hematopoietic Tumors 448

11.5.27 Sep 17, 2024: Liquid Biopsy Confirmed to Be Useful in Deciding on Adjuvant Therapy After Surgery for Colorectal Cancer Liver Metastases 449

11.5.28 Sep 17, 2024: Scrum-Japan Gozila Project: Large-Scale Study of Over 4,000 Cases Confirms Extension of Survival Time Through Personalized Cancer Medicine 450

11.5.29 Sep 16, 2024: Vazyme Leads Life Science Innovation, Boosting Research Breakthroughs in mIDH1 Cancer Treatment 451

11.5.30 Sep 01, 2024: Claritas HealthTech Furthers its Capabilities in Urology with ReDisys, a Computer Aided Detection Software for Kidney Cancer in CT Scans 451

11.5.31 Aug 23, 2024: Breakthroughs in Prostate Cancer: New Insights into Biomarkers and Probes 452

11.5.32 Aug 19, 2024: Nus and AStar Researchers Develop Wearable, Stretchable Sensor for Quick, Continuous, and Non-invasive Detection of Solid-State Skin Biomarkers 452

11.5.33 Aug 13, 2024: Precious2gpt: Multiomics Transformer and Conditional Diffusion for Generation of Multi-Omics Multi-Species Multi-Tissue Synthetic Biological Data 454

11.5.34 Aug 12, 2024: Chang Gung Cancer Proton Therapy Achieves Breakthrough 455

11.5.35 Aug 12, 2024: Promising New Target Discovered In Pancreatic Cancer Could Boost Chemotherapy And Reduce Spread 455

11.5.36 Aug 01, 2024: Development of a Method to Predict Onset of Non-Alcoholic Fatty Liver Disease —Contributing to Preventive Healthcare for Lifestyle Diseases 456

11.5.37 Jul 30, 2024: Biocon Foundation and IISc organize OCTF Conference on Artificial Intelligence in Oral Cancer 457

11.5.38 Jul 15, 2024: Peptomyc S.L. Expands Patent Portfolio with European and Indian Patent Grant for its Methods and Composition for the Treatment of Cancer 458

11.5.39 Jul 08, 2024: Noninvasive Urine Test for Early Detection of Cervical Cancer Virus Proteins 458

11.6 Strategy And Business Planning 459

11.6.1 May 30, 2025: Labcorp Expands Oncology Portfolio to Improve Patient Care and Advance Cancer Research 459

11.6.2 May 23, 2025: Qiagen and ID Solutions collaborate on dPCR assays for oncology research 460

11.6.3 May 08, 2025: Algorae Pharmaceuticals Partners with Peter MacCallum Cancer Centre for AIDriven Drug Synergy Screening 461

11.6.4 Apr 28, 2025: PredxBio and Hamamatsu Photonics Announce Strategic Partnership to Deliver Next-Generation Spatial Biology Solutions for Cancer Research and Therapeutic Development 461

11.6.5 Apr 15, 2025: BCAN Announces Partnerships With Ferring Pharmaceuticals and Astellas/Pfizer Alliance 462

11.6.6 Apr 14, 2025: JelloX Biotech Establishes US Research Base 462

11.6.7 Oct 29, 2024: American Oncology Network (AON) and Vantage Health Technologies Partner to Improve Cancer Patient Outcomes with AI-enabled Value-Based Care Platform 463

11.6.8 Sep 12, 2024: BioNexus Gene Lab Corp. Signs Strategic Partnership MOU with Shenzhen Rongguang Group to Advance Cancer Screening, Precision Medicine, and Preventative Healthcare Solutions 464

11.6.9 Jul 11, 2024: MGI Announces Collaboration With Predica Diagnostics 464

11.6.10 Jul 03, 2024: Rafarma Pharmaceutical Updates: Creation of a Joint Research and Production Enterprise in Busan (South Korea) Between Rafarma and the Korean Pharmaceutical Company Woods Medical Care 466

12 Appendix 467

12.1 Research Methodology 468

12.1.1 Coverage 468

12.1.2 Secondary Research 468

12.1.3 Primary Research 468

12.1.4 Market Modeling and Forecasting 469

12.1.5 Company Share Analysis 470

12.1.6 Benchmarking 471

12.2 GlobalData Consulting 472

12.3 Contact Us 472

12.4 Disclaimer 472

Table

Table 1: Oncology Market, Cross Country Comparison, Asia-Pacific, Revenue ($m), USD Constant, 2018-2033 23

Table 2: Oncology Market, Asia-Pacific, Revenue ($m), USD Constant, 2018-2033 25

Table 3: Oncology Market, Asia-Pacific, Volume (Units), 2018-2033 28

Table 4: Oncology Market, Asia-Pacific, Volume (Units), 2018-2033 30

Table 5: Oncology Market, Asia-Pacific, Company Share by Revenue ($m), 2024 33

Table 6: Oncology Market, China, Revenue ($m), USD Constant, 2018-2033 35

Table 7: ALK Tests Market, China, Revenue ($m), USD Constant, 2018-2033 38

Table 8: BCR-ABL Nucleic Acid Amplification Tests (NAATs) Market, China, Revenue ($m), USD Constant, 2018-2033 40

Table 9: BRAF Tests Market, China, Revenue ($m), USD Constant, 2018-2033 42

Table 10: BRCA Tests Market, China, Revenue ($m), USD Constant, 2018-2033 44

Table 11: Colorectal Cancer Screening Tests Market, China, Revenue ($m), USD Constant, 2018-2033 46

Table 12: EGFR Tests Market, China, Revenue ($m), USD Constant, 2018-2033 48

Table 13: HER2 Tests Market, China, Revenue ($m), USD Constant, 2018-2033 50

Table 14: KRAS Tests Market, China, Revenue ($m), USD Constant, 2018-2033 52

Table 15: Oncology Market, China, Volume (Units), 2018-2033 54

Table 16: ALK Tests Market, China, Volume (Units), 2018-2033 57

Table 17: BCR-ABL Nucleic Acid Amplification Tests (NAATs) Market, China, Volume (Units), 2018-2033 59

Table 18: BRAF Tests Market, China, Volume (Units), 2018-2033 61

Table 19: BRCA Tests Market, China, Volume (Units), 2018-2033 63

Table 20: Colorectal Cancer Screening Tests Market, China, Volume (Units), 2018-2033 65

Table 21: EGFR Tests Market, China, Volume (Units), 2018-2033 67

Table 22: HER2 Tests Market, China, Volume (Units), 2018-2033 69

Table 23: KRAS Tests Market, China, Volume (Units), 2018-2033 71

Table 24: Oncology Market, China, Average Price ($), 2018-2033 72

Table 25: Oncology Market, China, Company Share by Revenue ($m), 2024 76

Table 26: Oncology Market, South Korea, Revenue ($m), USD Constant, 2018-2033 78

Table 27: ALK Tests Market, South Korea, Revenue ($m), USD Constant, 2018-2033 81

Table 28: BCR-ABL Tests Market, South Korea, Revenue ($m), USD Constant, 2018-2033 83

Table 29: BRAF Tests Market, South Korea, Revenue ($m), USD Constant, 2018-2033 85

Table 30: BRCA Tests Market, South Korea, Revenue ($m), USD Constant, 2018-2033 87

Table 31: Colorectal Cancer Screening Tests Market, South Korea, Revenue ($m), USD Constant, 2018-2033 89

Table 32: EGFR Tests Market, South Korea, Revenue ($m), USD Constant, 2018-2033 91

Table 33: HER2 Tests Market, South Korea, Revenue ($m), USD Constant, 2018-2033 93

Table 34: KRAS Tests Market, South Korea, Revenue ($m), USD Constant, 2018-2033 95

Table 35: Oncology Market, South Korea, Volume (Units), 2018-2033 97

Table 36: ALK Tests Market, South Korea, Volume (Units), 2018-2033 100

Table 37: BCR-ABL Tests Market, South Korea, Volume (Units), 2018-2033 102

Table 38: BRAF Tests Market, South Korea, Volume (Units), 2018-2033 104

Table 39: BRCA Tests Market, South Korea, Volume (Units), 2018-2033 106

Table 40: Colorectal Cancer Screening Tests Market, South Korea, Volume (Units), 2018-2033 108

Table 41: EGFR Tests Market, South Korea, Volume (Units), 2018-2033 110

Table 42: HER2 Tests Market, South Korea, Volume (Units), 2018-2033 112

Table 43: KRAS Tests Market, South Korea, Volume (Units), 2018-2033 114

Table 44: Oncology Market, South Korea, Average Price ($), 2018-2033 115

Table 45: Oncology Market, South Korea, Company Share by Revenue ($m), 2024 120

Table 46: Oncology Market, Australia, Revenue ($m), USD Constant, 2018-2033 122

Table 47: ALK Tests Market, Australia, Revenue ($m), USD Constant, 2018-2033 125

Table 48: BCR-ABL Tests Market, Australia, Revenue ($m), USD Constant, 2018-2033 127

Table 49: BRAF Tests Market, Australia, Revenue ($m), USD Constant, 2018-2033 129

Table 50: BRCA Tests Market, Australia, Revenue ($m), USD Constant, 2018-2033 131

Table 51: Colorectal Cancer Screening Tests Market, Australia, Revenue ($m), USD Constant, 2018-2033 133

Table 52: EGFR Tests Market, Australia, Revenue ($m), USD Constant, 2018-2033 135

Table 53: HER2 Tests Market, Australia, Revenue ($m), USD Constant, 2018-2033 137

Table 54: KRAS Tests Market, Australia, Revenue ($m), USD Constant, 2018-2033 139

Table 55: Oncology Market, Australia, Volume (Units), 2018-2033 141

Table 56: ALK Tests Market, Australia, Volume (Units), 2018-2033 144

Table 57: BCR-ABL Tests Market, Australia, Volume (Units), 2018-2033 146

Table 58: BRAF Tests Market, Australia, Volume (Units), 2018-2033 148

Table 59: BRCA Tests Market, Australia, Volume (Units), 2018-2033 150

Table 60: Colorectal Cancer Screening Tests Market, Australia, Volume (Units), 2018-2033 152

Table 61: EGFR Tests Market, Australia, Volume (Units), 2018-2033 154

Table 62: HER2 Tests Market, Australia, Volume (Units), 2018-2033 156

Table 63: KRAS Tests Market, Australia, Volume (Units), 2018-2033 158

Table 64: Oncology Market, Australia, Average Price ($), 2018-2033 159

Table 65: Oncology Market, Australia, Company Share by Revenue ($m), 2024 164

Table 66: Oncology Market, India, Revenue ($m), USD Constant, 2018-2033 166

Table 67: ALK Tests Market, India, Revenue ($m), USD Constant, 2018-2033 169

Table 68: BCR-ABL Tests Market, India, Revenue ($m), USD Constant, 2018-2033 171

Table 69: BRAF Tests Market, India, Revenue ($m), USD Constant, 2018-2033 173

Table 70: BRCA Tests Market, India, Revenue ($m), USD Constant, 2018-2033 175

Table 71: Colorectal Cancer Screening Tests Market, India, Revenue ($m), USD Constant, 2018-2033 177

Table 72: EGFR Tests Market, India, Revenue ($m), USD Constant, 2018-2033 179

Table 73: HER2 Tests Market, India, Revenue ($m), USD Constant, 2018-2033 181

Table 74: KRAS Tests Market, India, Revenue ($m), USD Constant, 2018-2033 183

Table 75: Oncology Market, India, Volume (Units), 2018-2033 185

Table 76: ALK Tests Market, India, Volume (Units), 2018-2033 188

Table 77: BCR-ABL Tests Market, India, Volume (Units), 2018-2033 190

Table 78: BRAF Tests Market, India, Volume (Units), 2018-2033 192

Table 79: BRCA Tests Market, India, Volume (Units), 2018-2033 194

Table 80: Colorectal Cancer Screening Tests Market, India, Volume (Units), 2018-2033 196

Table 81: EGFR Tests Market, India, Volume (Units), 2018-2033 198

Table 82: HER2 Tests Market, India, Volume (Units), 2018-2033 200

Table 83: KRAS Tests Market, India, Volume (Units), 2018-2033 202

Table 84: Oncology Market, India, Average Price ($), 2018-2033 203

Table 85: Oncology Market, India, Company Share by Revenue ($m), 2024 208

Table 86: Oncology Market, Japan, Revenue ($m), USD Constant, 2018-2033 210

Table 87: ALK Tests Market, Japan, Revenue ($m), USD Constant, 2018-2033 213

Table 88: BCR-ABL Tests Market, Japan, Revenue ($m), USD Constant, 2018-2033 215

Table 89: BRAF Tests Market, Japan, Revenue ($m), USD Constant, 2018-2033 217

Table 90: BRCA Tests Market, Japan, Revenue ($m), USD Constant, 2018-2033 219

Table 91: Colorectal Cancer Screening Tests Market, Japan, Revenue ($m), USD Constant, 2018-2033 221

Table 92: EGFR Tests Market, Japan, Revenue ($m), USD Constant, 2018-2033 223

Table 93: HER2 Tests Market, Japan, Revenue ($m), USD Constant, 2018-2033 225

Table 94: KRAS Tests Market, Japan, Revenue ($m), USD Constant, 2018-2033 227

Table 95: Oncology Market, Japan, Volume (Units), 2018-2033 229

Table 96: ALK Tests Market, Japan, Volume (Units), 2018-2033 232

Table 97: BCR-ABL Tests Market, Japan, Volume (Units), 2018-2033 234

Table 98: BRAF Tests Market, Japan, Volume (Units), 2018-2033 236

Table 99: BRCA Tests Market, Japan, Volume (Units), 2018-2033 238

Table 100: Colorectal Cancer Screening Tests Market, Japan, Volume (Units), 2018-2033 240

Table 101: EGFR Tests Market, Japan, Volume (Units), 2018-2033 242

Table 102: HER2 Tests Market, Japan, Volume (Units), 2018-2033 244

Table 103: KRAS Tests Market, Japan, Volume (Units), 2018-2033 246

Table 104: Oncology Market, Japan, Average Price ($), 2018-2033 247

Table 105: Oncology Market, Japan, Company Share by Revenue ($m), 2024 251

Table 106: Oncology Market Pipeline Products 255

Table 107: Total Number of Primary Research Participants, In Vitro Diagnostics Market, by Country 469

Figures

Figure 1: Oncology Market, Cross Country Comparison, Asia-Pacific, Revenue ($m), USD Constant, 2018-2033 22

Figure 2: Oncology Market, Asia-Pacific, Revenue ($m), USD Constant, 2018-2033 24

Figure 3: Oncology Market, Asia-Pacific, Volume (Units), 2018-2033 27

Figure 4: Oncology Market, Asia-Pacific, Volume (Units), 2018-2033 29

Figure 5: Oncology Market, Asia-Pacific, Company Share (%), 2024 32

Figure 6: Oncology Market, China, Revenue ($m), USD Constant, 2018-2033 34

Figure 7: ALK Tests Market, China, Revenue ($m), USD Constant, 2018-2033 37

Figure 8: BCR-ABL Nucleic Acid Amplification Tests (NAATs) Market, China, Revenue ($m), USD Constant, 2018-2033 39

Figure 9: BRAF Tests Market, China, Revenue ($m), USD Constant, 2018-2033 41

Figure 10: BRCA Tests Market, China, Revenue ($m), USD Constant, 2018-2033 43

Figure 11: Colorectal Cancer Screening Tests Market, China, Revenue ($m), USD Constant, 2018-2033 45

Figure 12: EGFR Tests Market, China, Revenue ($m), USD Constant, 2018-2033 47

Figure 13: HER2 Tests Market, China, Revenue ($m), USD Constant, 2018-2033 49

Figure 14: KRAS Tests Market, China, Revenue ($m), USD Constant, 2018-2033 51

Figure 15: Oncology Market, China, Volume (Units), 2018-2033 53

Figure 16: ALK Tests Market, China, Volume (Units), 2018-2033 56

Figure 17: BCR-ABL Tests Market, China, Volume (Units), 2018-2033 58

Figure 18: BRAF Tests Market, China, Volume (Units), 2018-2033 60

Figure 19: BRCA Tests Market, China, Volume (Units), 2018-2033 62

Figure 20: Colorectal Cancer Screening Tests Market, China, Volume (Units), 2018-2033 64

Figure 21: EGFR Tests Market, China, Volume (Units), 2018-2033 66

Figure 22: HER2 Tests Market, China, Volume (Units), 2018-2033 68

Figure 23: KRAS Tests Market, China, Volume (Units), 2018-2033 70

Figure 24: Oncology Market, China, Company Share (%), 2024 75

Figure 25: Oncology Market, South Korea, Revenue ($m), USD Constant, 2018-2033 77

Figure 26: ALK Tests Market, South Korea, Revenue ($m), USD Constant, 2018-2033 80

Figure 27: BCR-ABL Tests Market, South Korea, Revenue ($m), USD Constant, 2018-2033 82

Figure 28: BRAF Tests Market, South Korea, Revenue ($m), USD Constant, 2018-2033 84

Figure 29: BRCA Tests Market, South Korea, Revenue ($m), USD Constant, 2018-2033 86

Figure 30: Colorectal Cancer Screening Tests Market, South Korea, Revenue ($m), USD Constant, 2018-2033 88

Figure 31: EGFR Tests Market, South Korea, Revenue ($m), USD Constant, 2018-2033 90

Figure 32: HER2 Tests Market, South Korea, Revenue ($m), USD Constant, 2018-2033 92

Figure 33: KRAS Tests Market, South Korea, Revenue ($m), USD Constant, 2018-2033 94

Figure 34: Oncology Market, South Korea, Volume (Units), 2018-2033 96

Figure 35: ALK Tests Market, South Korea, Volume (Units), 2018-2033 99

Figure 36: BCR-ABL Tests Market, South Korea, Volume (Units), 2018-2033 101

Figure 37: BRAF Tests Market, South Korea, Volume (Units), 2018-2033 103

Figure 38: BRCA Tests Market, South Korea, Volume (Units), 2018-2033 105

Figure 39: Colorectal Cancer Screening Tests Market, South Korea, Volume (Units), 2018-2033 107

Figure 40: EGFR Tests Market, South Korea, Volume (Units), 2018-2033 109

Figure 41: HER2 Tests Market, South Korea, Volume (Units), 2018-2033 111

Figure 42: KRAS Tests Market, South Korea, Volume (Units), 2018-2033 113

Figure 43: Oncology Market, South Korea, Company Share (%), 2024 119

Figure 44: Oncology Market, Australia, Revenue ($m), USD Constant, 2018-2033 121

Figure 45: ALK Tests Market, Australia, Revenue ($m), USD Constant, 2018-2033 124

Figure 46: BCR-ABL Tests Market, Australia, Revenue ($m), USD Constant, 2018-2033 126

Figure 47: BRAF Tests Market, Australia, Revenue ($m), USD Constant, 2018-2033 128

Figure 48: BRCA Tests Market, Australia, Revenue ($m), USD Constant, 2018-2033 130

Figure 49: Colorectal Cancer Screening Tests Market, Australia, Revenue ($m), USD Constant, 2018-2033 132

Figure 50: EGFR Tests Market, Australia, Revenue ($m), USD Constant, 2018-2033 134

Figure 51: HER2 Tests Market, Australia, Revenue ($m), USD Constant, 2018-2033 136

Figure 52: KRAS Tests Market, Australia, Revenue ($m), USD Constant, 2018-2033 138

Figure 53: Oncology Market, Australia, Volume (Units), 2018-2033 140

Figure 54: ALK Tests Market, Australia, Volume (Units), 2018-2033 143

Figure 55: BCR-ABL Tests Market, Australia, Volume (Units), 2018-2033 145

Figure 56: BRAF Tests Market, Australia, Volume (Units), 2018-2033 147

Figure 57: BRCA Tests Market, Australia, Volume (Units), 2018-2033 149

Figure 58: Colorectal Cancer Screening Tests Market, Australia, Volume (Units), 2018-2033 151

Figure 59: EGFR Tests Market, Australia, Volume (Units), 2018-2033 153

Figure 60: HER2 Tests Market, Australia, Volume (Units), 2018-2033 155

Figure 61: KRAS Tests Market, Australia, Volume (Units), 2018-2033 157

Figure 62: Oncology Market, Australia, Company Share (%), 2024 163

Figure 63: Oncology Market, India, Revenue ($m), USD Constant, 2018-2033 165

Figure 64: ALK Tests Market, India, Revenue ($m), USD Constant, 2018-2033 168

Figure 65: BCR-ABL Tests Market, India, Revenue ($m), USD Constant, 2018-2033 170

Figure 66: BRAF Tests Market, India, Revenue ($m), USD Constant, 2018-2033 172

Figure 67: BRCA Tests Market, India, Revenue ($m), USD Constant, 2018-2033 174

Figure 68: Colorectal Cancer Screening Tests Market, India, Revenue ($m), USD Constant, 2018-2033 176

Figure 69: EGFR Tests Market, India, Revenue ($m), USD Constant, 2018-2033 178

Figure 70: HER2 Tests Market, India, Revenue ($m), USD Constant, 2018-2033 180

Figure 71: KRAS Tests Market, India, Revenue ($m), USD Constant, 2018-2033 182

Figure 72: Oncology Market, India, Volume (Units), 2018-2033 184

Figure 73: ALK Tests Market, India, Volume (Units), 2018-2033 187

Figure 74: BCR-ABL Tests Market, India, Volume (Units), 2018-2033 189

Figure 75: BRAF Tests Market, India, Volume (Units), 2018-2033 191

Figure 76: BRCA Tests Market, India, Volume (Units), 2018-2033 193

Figure 77: Colorectal Cancer Screening Tests Market, India, Volume (Units), 2018-2033 195

Figure 78: EGFR Tests Market, India, Volume (Units), 2018-2033 197

Figure 79: HER2 Tests Market, India, Volume (Units), 2018-2033 199

Figure 80: KRAS Tests Market, India, Volume (Units), 2018-2033 201

Figure 81: Oncology Market, India, Company Share (%), 2024 207

Figure 82: Oncology Market, Japan, Revenue ($m), USD Constant, 2018-2033 209

Figure 83: ALK Tests Market, Japan, Revenue ($m), USD Constant, 2018-2033 212

Figure 84: BCR-ABL Tests Market, Japan, Revenue ($m), USD Constant, 2018-2033 214

Figure 85: BRAF Tests Market, Japan, Revenue ($m), USD Constant, 2018-2033 216

Figure 86: BRCA Tests Market, Japan, Revenue ($m), USD Constant, 2018-2033 218

Figure 87: Colorectal Cancer Screening Tests Market, Japan, Revenue ($m), USD Constant, 2018-2033 220

Figure 88: EGFR Tests Market, Japan, Revenue ($m), USD Constant, 2018-2033 222

Figure 89: HER2 Tests Market, Japan, Revenue ($m), USD Constant, 2018-2033 224

Figure 90: KRAS Tests Market, Japan, Revenue ($m), USD Constant, 2018-2033 226

Figure 91: Oncology Market, Japan, Volume (Units), 2018-2033 228

Figure 92: ALK Tests Market, Japan, Volume (Units), 2018-2033 231

Figure 93: BCR-ABL Tests Market, Japan, Volume (Units), 2018-2033 233

Figure 94: BRAF Tests Market, Japan, Volume (Units), 2018-2033 235

Figure 95: BRCA Tests Market, Japan, Volume (Units), 2018-2033 237

Figure 96: Colorectal Cancer Screening Tests Market, Japan, Volume (Units), 2018-2033 239

Figure 97: EGFR Tests Market, Japan, Volume (Units), 2018-2033 241

Figure 98: HER2 Tests Market, Japan, Volume (Units), 2018-2033 243

Figure 99: KRAS Tests Market, Japan, Volume (Units), 2018-2033 245

Figure 100: Oncology Market, Japan, Company Share (%), 2024 250

Asia-Pacific Oncology Market Outlook to 2033: Colorectal Cancer Screening Tests, EGFR Tests, KRAS Tests and Others standard reports
Currency USD
$5,995

Can be used by individual purchaser only

Most Popular
$11,990

Can be shared by unlimited users within one corporate location e.g. a regional office

$17,985

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Add to Basket

Undecided about purchasing this report?

Enquire Before Buying

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

See what our customers are saying
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

 Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

 Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

 Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

 Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

 Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

 Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

 Senior Account Manager, TSYS

Related reports

View more In Vitro Diagnostics reports
Medical Devices
New
Transcatheter Pulmonary Valve Replacement (TPVR) Market Size by Segments, Share,…
$7,500 | April 2026
Medical Devices
New
Intravascular Ultrasound System (IVUS) Consoles Market Size by Segments, Share,…
$7,500 | April 2026
Medical Devices
New
Dialysis Machines Market Size by Segments, Share, Regulatory, Reimbursement, Installed…
$7,500 | April 2026
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Asia-Pacific Oncology Market Outlook to 2033: Colorectal Cancer Screening Tests, EGFR Tests, KRAS Tests and Others in real time.

  • Access a live Asia-Pacific Oncology Market Outlook to 2033: Colorectal Cancer Screening Tests, EGFR Tests, KRAS Tests and Others dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.
Tell me more